BBIO vs RPRX

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 02, 2026

BBIO

75.9
AI Score
VS
BBIO Wins

RPRX

70.3
AI Score

Investment Advisor Scores

BBIO

Oct 02, 2026
76score
Recommendation
HOLD

RPRX

Oct 02, 2026
70score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric BBIO RPRX Winner
Forward P/E 0 29.4118 Tie
PEG Ratio 0 1.3431 Tie
Revenue Growth 120.4% 16.5% BBIO
Earnings Growth 0.0% -46.3% BBIO
Tradestie Score 75.9/100 70.3/100 BBIO
Profit Margin -97.0% 32.0% RPRX
Beta 1.00 1.00 Tie
Implied Volatility N/A N/A Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

BBIO 1M: -12.1% · 3M: -13.5% RPRX 1M: -9.4% · 3M: +0.4%

Current Technical Phase

BBIO

Markdown
Sell / avoid

Price below a falling SMA50 (slope -5.2%), weak momentum, RSI 38

RSI (14): 38.0 · Price: $67.25

RPRX

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 37

RSI (14): 37.1 · Price: $57.16

Fundamentals Snapshot

Metric BBIO RPRX
Market Cap — —
Forward P/E 2445.5 10.0
Trailing P/E — 31.3
Revenue (TTM) — —
Revenue Growth 1.2% 0.2%
Gross Margin 0.9% 1.0%
Operating Margin -0.4% 0.2%
EPS -3.62 1.84
Dividend Yield — 0.02%

Frequently Asked Questions

Based on our detailed analysis, BBIO is currently the stronger investment candidate, winning 3 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.